Clinical Trials on Breast Diseases
Total 379764 results
-
Abramson Cancer Center at Penn MedicineRecruitingBreast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | ER Positive Breast CancerUnited States
-
Fundacao ChampalimaudNot yet recruitingTriple Negative Breast Cancer | Early Breast CancerPortugal
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingMetastatic Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerAustria, Belgium, Italy, Spain, France, Switzerland, Denmark, Norway, Sweden
-
UNICANCERGilead SciencesRecruitingMetastatic Breast Cancer | Triple Negative Breast CancerFrance
-
Fondazione Sandro PitiglianiClinical Research Technology S.r.l.RecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerItaly
-
Imperial College LondonMedical Research Council; ECMCRecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerUnited Kingdom
-
University of MichiganNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Acrotech Biopharma Inc.CompletedBreast Cancer | Breast Tumors | Neoplasms, Breast | Cancer of the Breast | Human Mammary CarcinomaFrance, United States, Czechia, Hungary
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)Terminated
-
PIQUR Therapeutics AGHospital Universitari Vall d'Hebron Research Institute; Institut Català d'Oncologia and other collaboratorsCompletedMetastatic Breast CancerSpain, United Kingdom
-
AstraZenecaCompletedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerBelgium, Canada, Austria, Australia
-
Fudan UniversityUnknownMetastatic Breast CancerChina
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2/Neu-positive Breast CancerUnited States
-
Infinity Pharmaceuticals, Inc.TerminatedBreast Cancer | Metastatic Breast Cancer | HER2 Positive Breast Cancer | Cancer of the BreastUnited States, Spain
-
Case Comprehensive Cancer CenterWithdrawnStage I Breast Cancer | HER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast... and other conditionsUnited States
-
Universidad Miguel Hernandez de ElcheCompletedBreast Feeding | Postpartum Breast Disorders
-
Swiss Group for Clinical Cancer ResearchNot yet recruitingTriple-negative Breast Cancer | TNBC - Triple-Negative Breast CancerSwitzerland
-
H. Lee Moffitt Cancer Center and Research InstituteFlorida Breast Cancer FoundationRecruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor-positive Breast CancerUnited States
-
University of VirginiaRecruitingBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage IIIUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi SankyoRecruitingAdvanced Breast Cancer | HER2-positive Metastatic Breast Cancer | Breast Cancer Metastatic | HER2 Low Breast CarcinomaFrance
-
University of Alabama at BirminghamSusan G. Komen Breast Cancer Foundation; Daiichi Sankyo UK Ltd.; Triple Negative...CompletedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Stage IV Breast CancerUnited States
-
BioPharmX, Inc.CompletedFibrocystic Breast Condition (FBC)United States, Canada
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedStage 0 Breast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast CancerUnited States
-
Filipa Lynce, MDAstraZeneca; Daiichi Sankyo, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | Invasive Breast Cancer | Inflammatory Breast Cancer Stage III | HER2 Low Breast AdenocarcinomaUnited States
-
Rhizen Pharmaceuticals SAIncozen Therapeutics Pvt LtdRecruitingTriple Negative Breast Cancer (TNBC)India
-
Fudan UniversityRecruiting
-
Mridula George, MDRecruitingOCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast CancerTriple Negative Breast Cancer (TNBC)United States
-
Karolinska University HospitalRecruitingMetastatic Triple-Negative Breast CarcinomaSweden
-
Shanghai Jiaolian Drug Research and Development...Shanghai Pharmaceuticals Holding Co., LtdRecruitingTriple Negative Breast Cancer (TNBC)China
-
Beijing 302 HospitalRecruitingTNBC - Triple-Negative Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingMetastatic Triple-Negative Breast CancerChina
-
University of Texas Southwestern Medical CenterGateway for Cancer Research; Celldex TherapeuticsRecruitingMetastatic Triple Negative Breast CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Triple Negative Breast CancerAustralia
-
Novartis PharmaceuticalsTerminatedTriple Negative Breast Cancer (TNBC)Netherlands, Spain, Hong Kong, Singapore, Italy, Australia, Israel, Japan, United States
-
Calithera Biosciences, IncCompletedTriple Negative Breast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
ImmunityBio, Inc.WithdrawnTriple Negative Breast Cancer (TNBC)United States
-
Veru Inc.WithdrawnMetastatic Triple Negative Breast Cancer
-
Istituto Scientifico Romagnolo per lo Studio e...Agenzia Italiana del FarmacoUnknownMetastatic Breast Cancer | Hormone Receptor Positive Breast Cancer | Hormone Receptor Negative Breast CancerItaly
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownTriple Negative Breast Cancer (TNBC)China
-
National Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
University of WashingtonUnited States Department of Defense; Breast Cancer AllianceActive, not recruitingStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Stage III Breast Cancer | HER2 Negative Breast CarcinomaUnited States
-
George W. Sledge Jr.National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2 Positive Breast Carcinoma | Stage III Breast CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IIIC Breast Cancer | HER2/Neu Negative | Stage III Breast Cancer | Postmenopausal | Estrogen Receptor StatusUnited States
-
Hebei Medical University Fourth HospitalRecruitingAdvanced Breast Cancer | HER2-positive Breast CancerChina
-
Spanish Breast Cancer Research GroupAstraZenecaRecruitingMetastatic Breast Cancer | Locally Advanced Breast CancerSpain
-
Institut fuer FrauengesundheitSamsung Bioepis Co., Ltd.RecruitingBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer FemaleGermany
-
Saint Luke's Health SystemNovartis PharmaceuticalsRecruitingMetastatic Breast Cancer | HER2-negative Breast CancerUnited States
-
Royal Marsden NHS Foundation TrustPfizer; AstraZeneca; Institute of Cancer Research, United Kingdom; UNICANCER; Gustave... and other collaboratorsRecruitingHER2-negative Breast Cancer | ER+ Breast CancerUnited Kingdom, France
-
Wake Forest University Health SciencesAtrium Health NavicentActive, not recruitingBreast Cancer Female | Early-stage Breast CancerUnited States